If you made any changes in Pure these will be visible here soon.

Research Output 1984 2019

Filter
Review article
2019

How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

Santini, D., Galvano, A., Pantano, F., Incorvaia, L., Rizzo, S., Vincenzi, B., Castellana, L., Giuliana, G., Guadagni, F., Toia, F., Tonini, G., Russo, A., Badalamenti, G. & Bazan, V., Oct 2019, In : Critical Reviews in Oncology/Hematology. 142, p. 68-75 8 p.

Research output: Contribution to journalReview article

zoledronic acid
Meta-Analysis
Appointments and Schedules
Morbidity
Hypocalcemia

Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models

Riondino, S., Ferroni, P., Zanzotto, F. M., Roselli, M. & Guadagni, F., Jan 1 2019, In : Cancers. 11, 1, 95.

Research output: Contribution to journalReview article

Open Access
Venous Thromboembolism
Biomarkers
Neoplasms
Drug Therapy
Primary Prevention

Proposed tandem effect of physical activity and sirtuin 1 and 3 activation in regulating glucose homeostasis

Pacifici, F., Di Cola, D., Pastore, D., Abete, P., Guadagni, F., Donadel, G., Bellia, A., Esposito, E., Salimei, C., Salimei, P. S., Ricordi, C., Lauro, D. & Della-Morte, D., Oct 1 2019, In : International Journal of Molecular Sciences. 20, 19, 4748.

Research output: Contribution to journalReview article

Open Access
Sirtuin 3
Sirtuin 1
Sirtuins
homeostasis
diabetes mellitus
2017

Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer

Riondino, S., Del Monte, G., Fratangeli, F., Guadagni, F., Roselli, M. & Ferroni, P., Apr 1 2017, In : Cardiovascular and Hematological Agents in Medicinal Chemistry. 15, 1, p. 3-16 14 p.

Research output: Contribution to journalReview article

Angiogenesis Inhibitors
Thromboembolism
Drug-Related Side Effects and Adverse Reactions
Vascular Endothelial Growth Factor A
Blood Vessels

Ketogenic diet and other dietary intervention strategies in the treatment of cancer

Vergati, M., Krasniqi, E., Monte, G. D., Riondino, S., Vallone, D., Guadagni, F., Ferroni, P. & Roselli, M., Jan 1 2017, In : Current Medicinal Chemistry. 24, 12, p. 1170-1185 16 p.

Research output: Contribution to journalReview article

Ketogenic Diet
Nutrition
Cells
Tumors
Metabolism

Sex-genetic interaction in the risk for cerebrovascular disease

Pastore, D., Pacifici, F., Capuani, B., Palmirotta, R., Dong, C., Coppola, A., Abete, P., Roselli, M., Sbraccia, P., Guadagni, F., Lauro, D., Rundek, T. & Della-Morte, D., Jul 1 2017, In : Current Medicinal Chemistry. 24, 24, p. 2687-2699 13 p.

Research output: Contribution to journalReview article

Cerebrovascular Disorders
Stroke
Genetic Phenomena
Genetically Modified Animals
Incidence
2016

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition

Palmirotta, R., Cives, M., Della-Morte, D., Capuani, B., Lauro, D., Guadagni, F. & Silvestris, F., 2016, In : Oxidative Medicine and Cellular Longevity. 2016, 3031459.

Research output: Contribution to journalReview article

Sirtuins
Epithelial-Mesenchymal Transition
Neoplasms
Group III Histone Deacetylases
Metabolic Networks and Pathways

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators

Capuani, B., Pacifici, F., Pastore, D., Palmirotta, R., Donadel, G., Arriga, R., Bellia, A., Di Daniele, N., Rogliani, P., Abete, P., Sbraccia, P., Guadagni, F., Lauro, D. & Della-Morte, D., Sep 1 2016, In : Pharmacological Research. 111, p. 659-667 9 p.

Research output: Contribution to journalReview article

Protein Kinase C-epsilon
Acute Disease
Chronic Disease
Phosphotransferases
Pharmacology